Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSoegiharto, Reineke
dc.contributor.authorAghdam, Mehran Alizadeh
dc.contributor.authorSorensen, Jennifer Astrup
dc.contributor.authorvan Lindonk, Esmee
dc.contributor.authorDemir, Ferhan Bulut
dc.contributor.authorPorras, Nasser Mohammad
dc.contributor.authorMatsuo, Yoshimi
dc.contributor.authorKiefer, Lea
dc.contributor.authorKnulst, Andre C.
dc.contributor.authorMaurer, Marcus
dc.contributor.authorRitchie, Carla
dc.contributor.authorRudenko, Michael
dc.contributor.authorKocatuerk, Emek
dc.contributor.authorCriado, Roberta F. J.
dc.contributor.authorGregoriou, Stamatis
dc.contributor.authorBobylev, Tatjana
dc.contributor.authorKleinheinz, Andreas
dc.contributor.authorTakahagi, Shunsuke
dc.contributor.authorHide, Michihiro
dc.contributor.authorGimenez\\-Arnau, Ana M.
dc.contributor.authorSalman, Andac
dc.contributor.authorKara, Rabia O.
dc.contributor.authorDikicier, Bahar Sevimli
dc.contributor.authorvan Doorn, Martijn B. A.
dc.contributor.authorThomsen, Simon F.
dc.contributor.authorvan den Reek, Juul M. P. A.
dc.contributor.authorRockmann, Heike
dc.date.accessioned2025-10-16T15:12:56Z
dc.date.issued2024
dc.identifier.doi10.1001/jamadermatol.2024.2056
dc.identifier.otherWOS:001272861600004
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5680
dc.publisherAMER MEDICAL ASSOC
dc.sourceJAMA DERMATOLOGY
dc.titleMultinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS